29 June 2018 - FDA Commissioner Scott Gottlieb says anything that makes much needed products more accessible to consumers and lowers costs is a good thing.

FDA Commissioner Scott Gottlieb says Amazon's new push into health care is just fine because anything that makes much needed products, like pharmaceuticals, more accessible to consumers and lowers costs is a positive.

"Disruptive competition is a good thing," Gottlieb said Friday in an interview with CNBC's "Squawk Box."

"The supply chain, the intermediaries, are a cost on the system. So, seeing more competition into that marketplace will help bring down costs, maybe promote use of generics."

Read CNBC News article